Eclipse Biotech Private Limited
About Eclipse Biotech Private Limited
Data last updated:
Eclipse Biotech Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the research and development sector. It was incorporated on 26 July 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74900PN2012PTC144195. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandhyarani Shrikant Bongale and Sumant Anant Hippargekar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mohite Residency Flat 2 Vitthalwadi Hingne Khurd, Pune, Maharashtra, India – 411005.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.12 Lakh, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹6,399 (net margin 1%) and EBITDA of ₹8,638 (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 26% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Eclipse Biotech Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressMohite Residency Flat 2 Vitthalwadi Hingne Khurd, Pune, Maharashtra, India – 411005
- IndustryResearch & Development, Research & Development
To see the full contact details of Eclipse Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Eclipse Biotech is electricity, gas, steam and air conditioning supply. In detail, this covers electricity, gas, steam and air conditioning supply.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| D | Electricity, gas, steam and air conditioning supply | 35 | Electricity, gas, steam and air conditioning supply |
To see the full business activity and turnover split of Eclipse Biotech Private Limited, buy the company report.
Financials of Eclipse Biotech Private Limited
FY 2025 filings availableEclipse Biotech Private Limited reported revenue of ₹6.12 Lakh (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 26% over five years, including 22% growth in the latest year. EBITDA fell 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8,638 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6,399 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eclipse Biotech Private Limited, buy the company report.
Board of directors of Eclipse Biotech Private Limited
Eclipse Biotech has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandhyarani Shrikant Bongale | Director | 26 Jul 2012 | 14 Years 2 Months | Current |
| Sumant Anant Hippargekar Also directs: Pine Desk Space Solutions LLP, Indapur Agro Farmers Producer Company Limited, Vastutek Steel Technology Private Limited and 2 more | Director | 01 Oct 2017 | 9 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Eclipse Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eclipse Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Eclipse Biotech has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Eclipse Biotech Private Limited, buy the company report.
Recent activity
Eclipse Biotech Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Sumant Anant Hippargekar ceased to be Additional Director on 29 Sep 2018.
Frequently asked questions
Eclipse Biotech is an active private limited company based in Pune, Maharashtra, India. The company works in the research and development industry. It was incorporated on 26 July 2012 (14+ years old) and is registered under CIN U74900PN2012PTC144195.
Eclipse Biotech has 2 current directors:
- Sandhyarani Shrikant Bongale - Director
- Sumant Anant Hippargekar - Director
The latest financial statements of Eclipse Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Eclipse Biotech has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Eclipse Biotech is U74900PN2012PTC144195. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eclipse Biotech was incorporated on 26 July 2012, making it 14+ years old. It is registered with the Registrar of Companies, Pune.
Sumant Anant Hippargekar ceased to be Additional Director on 29 Sep 2018. Balbhim Abhiman Bongale ceased to be Director on 07 Oct 2017. Sumant Anant Hippargekar was appointed as Director on 01 Oct 2017. Eclipse Biotech has 4 board changes on record in total.
The registered office of Eclipse Biotech is at Mohite Residency Flat 2 Vitthalwadi Hingne Khurd, Pune, Maharashtra, India – 411005.
Eclipse Biotech operates in the research and development industry.
The compliance status of Eclipse Biotech is active non-compliant as of 28 July 2026. The company is actively filing with the Registrar of Companies.